Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Prevention and Intervention Approaches for Fetal Alcohol…

U.S. National Institutes of Health·United States of America

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Closes 1/7/2027$200k – $1MGrants Notice
Get bids like this by emailBid source

Description

This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances prevention approaches to reduce prenatal alcohol exposure and incidence of FASD and interventions for FASD. Key aspects of this opportunity include: • Prevention approaches to reduce prenatal alcohol exposure and incidence of FASD • Interventions for FASD • Research that advances the understanding of FASD throughout the lifespan • Support for studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale FASD prevention or intervention studies

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

[email protected]

(301) 402-2541

Key dates

Opened
11/22/2023
Closes
1/7/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541720
Solicitation №
PAR-25-159

Budget estimate

$200,000 – $1,000,000

Given the nature of the grant, it is difficult to estimate the exact budget. However, considering the funding instrument is a grant and the award ceiling and floor are not specified, a rough estimate could be between $200,000 and $1,000,000. This estimate is based on the fact that the grant is for research and development, and the funding agency is the National Institutes of Health. The actual budget may vary depending on the scope and complexity of the proposed research project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 97%

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Closes 11/17/2026Opened 11/22/2023

U.S. National Institutes of Health·United States of America

90% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

86% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. National Institutes of Health·United States of America

85% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

85% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

83% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

83% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. National Institutes of Health·United States of America

82% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

81% match

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 2/8/2021

U.S. National Institutes of Health·United States of America

81% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. Food and Drug Administration·United States of America

81% match

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Closes 5/16/2028Opened 7/11/2025

U.S. National Institutes of Health·United States of America

81% match

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 9/11/2023

U.S. National Institutes of Health·United States of America

81% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

80% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

80% match

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

Closes 11/15/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

80% match

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)

Closes 1/7/2028Opened 11/25/2024

U.S. Centers for Disease Control - NCIPC·United States of America

80% match

Preventing Violence Affecting Young Lives (PREVAYL 2.0)

Closes 6/1/2027Opened 8/17/2026

U.S. National Institutes of Health·United States of America

80% match

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 5/10/2022

U.S. Centers for Disease Control - NCBDDD·United States of America

80% match

Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge

Closes 5/25/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

80% match

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Closes 6/15/2028Opened 9/25/2025

U.S. National Institutes of Health·United States of America

79% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

79% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

79% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

79% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

79% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023